Genentech Pulmozyme recall

Firm recalls one lot (216,000 ampules) of dornase alfa cystic fibrosis therapy after FDA notes use of unapproved refiltration step to remove metal particulates that entered bulk drug substance after a valve leak. Genentech recalled 23 lots of Pulmozyme in March due to potential packaging defects